MedTrace Logo

Therapies for Treatment-Resistant Panic Disorder Symptoms

NCT00118417 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2014-06-11

Study results available
· View outcomes & findings →

Summary

This study will determine the effectiveness of different treatments for panic disorder symptoms in individuals who still have symptoms after initial treatment with medication.

Conditions

  • Panic Disorder

Interventions

DRUG

Clonazepam

Participants will receive clonazepam.

DRUG

Sertraline

Participants will receive sertraline.

BEHAVIORAL

Cognitive behavioral therapy

Participants will receive cognitive behavioral therapy

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Naomi M. Simon, MD, MSc · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-03-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00118417 on ClinicalTrials.gov